14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Thu, 9 May 2024

Trading levels for GTBP

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 3.35 3.72 %
R2 3.30 2.30 %
R1 3.28 1.42 %
Current price: 3.23
Support S1 3.18 -1.42 %
S2 3.16 -2.30 %
S3 3.11 -3.72 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 3.77 16.72 %
R2 3.76 16.25 %
R1 3.65 13.00 %
Current price 3.23
Support S1 3.22 -0.310%
S2 3.11 -3.80%
S3 3.00 -7.12%

GTBP Predictions History

2 years ago
timsmithinvesting.223838 predicted that GTBP for 2021-07-07 is going

Rank:

2 years ago
Cherie Lynn Auletta predicted that GTBP for 2021-07-07 is going

Rank:

2 years ago
JS predicted that GTBP for 2021-06-15 is going $17.61 (1.85%)

2 years ago
stockmark9t.243841 predicted that GTBP for 2021-06-15 is going

Rank:

2 years ago
artravler535.243205 predicted that GTBP for 2021-06-11 is going

Rank:

3 years ago
JS predicted that GTBP for 2021-03-29 is going $6.64 (-2.78%)

Click to get the best stock tips daily for free!

About GT Biopharma, Inc.

GT Biopharma. GT Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology products based on its proprietary Tri-specific Killer Engager (TriKE) fusion protein immune cell engager technology platform. It develops GTB-3550, a single-chain tri-specific recombinant fusion protein conjugate that is in Phase I/II clinical trial for the treatment of myelodysplastic syndromes, refractory/relapsed ... GTBP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT